Monthwise SARS CoV-2 mutation statistics
Position | Mutation | Clade |
---|---|---|
354 | nsp4:T354A; | CL-1a_3d;CL-3b;CL-3e; |
354 | nsp4:T354I; | CL-3b;CL-3c;CL-3d; |
37 | nsp4:T37-; | CL-3e;CL-3f;CL-5; |
370 | nsp4:T370I; | CL-3e; |
378 | nsp4:T378I; | CL-5; |
37 | nsp4:T37N; | CL-1a_3e;CL-3e; |
419 | nsp4:T419-; | CL-3b;CL-3e; |
419 | nsp4:T419I; | CL-3b;CL-3d;CL-3e; |
439 | nsp4:T439-; | CL-3b;CL-3e; |
460 | nsp4:T460-; | CL-3e; |
460 | nsp4:T460I; | CL-1a; |
461 | nsp4:T461I; | CL-3b;CL-3c;CL-3d; |
492 | nsp4:T492-; | CL-1a_3e;CL-1b;CL-3b;CL-3d;CL-3e; |
54 | nsp4:T54I; | CL-1b; |
60 | nsp4:T60-; | CL-3e;CL-3f; |
60 | nsp4:T60K; | CL-3f; |
62 | nsp4:T62-; | CL-1a;CL-3b;CL-3e;CL-3f; |
73 | nsp4:T73-; | CL-1a;CL-3b;CL-3d;CL-3f; |
73 | nsp4:T73A; | CL-3d; |
73 | nsp4:T73S; | CL-3e; |
83 | nsp4:T83-; | CL-3b;CL-3e;CL-3f; |
96 | nsp4:T96-; | CL-3e; |
102 | nsp4:V102I; | CL-3b;CL-3e; |
103 | nsp4:V103-; | CL-3b;CL-3e; |
103 | nsp4:V103A; | CL-3d; |
103 | nsp4:V103E; | CL-3b; |
103 | nsp4:V103L; | CL-3b;CL-3f; |
125 | nsp4:V125-; | CL-3e; |
125 | nsp4:V125I; | CL-2; |
129 | nsp4:V129-; | CL-1a_3d; |
129 | nsp4:V129I; | CL-2; |
13 | nsp4:V13-; | CL-3e; |
13 | nsp4:V13F; | CL-3d; |
151 | nsp4:V151-; | CL-3e; |
16 | nsp4:V16-; | CL-3d;CL-3e; |
167 | nsp4:V167A; | CL-3b; |
167 | nsp4:V167I; | CL-3b; |
167 | nsp4:V167L; | CL-3b; |
16 | nsp4:V16A; | CL-2;CL-3d; |
175 | nsp4:V175I; | CL-1a_3a; |
180 | nsp4:V180-; | CL-3b; |
180 | nsp4:V180F; | CL-3e; |
192 | nsp4:V192L; | CL-3e; |
20 | nsp4:V20-; | CL-1b; |
20 | nsp4:V20A; | CL-3b; |
20 | nsp4:V20F; | CL-1a_3e;CL-3b;CL-3e; |
210 | nsp4:V210I; | CL-3d;CL-5; |
212 | nsp4:V212L; | CL-1b; |
213 | nsp4:V213I; | CL-3e; |
213 | nsp4:V213L; | CL-1a_3c;CL-3c; |
Page 320 of 409
Tutorial Link
For More Web Development Tutorials Visit: AllPHPTricks.com